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Recent studies regarding somatic hypermutation of immuno-
globulin genes show that both MALT lymphoma and Walden-
stro¨m’s macroglobulinemia are tumors of hypermutated post
germinal center B lymphocytes that have undergone antigen
selection.1,7 All together, these data suggest a close relation-
ship between these two entities from the perspective of cellu-
lar origin.
The maturation of small lymphoid cells into plasma cells,
characteristic of Waldenstro¨m’s macroglobulinemia, is also
observed in 30–40% of low-grade MALT lymphomas. How-
ever, the appearance of a serum monoclonal component
seems uncommon in MALT lymphoma. It has been reported
in only one case of MALT lymphoma,2 and seems much more
common in the closely related nodal marginal zone B cell
lymphomas.6 The presence of a serum monoclonal compo-
nent in MALT lymphoma might be due to extra-mucosal
dissemination of the disease, especially in bone marrow, as
illustrated in our first patient.
In conclusion, disseminated MALT lymphoma may mimick
WM. Our observations suggest that some cases of MW
with gastrointestinal involvement many in fact constitute
disseminated forms of low-grade MALT lymphoma.
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TO THE EDITOR
Leukemic cells have been considered as the malignant
counterpart of hematopoietic cells arrested at different stages
of maturation. However, acute leukemias may occasionally
display histochemical staining properties and/or cell surface
antigens of more than one hematopoietic lineage and are
considered hybrid leukemias.1 This heterogeneity has been
extended to the genomic level. Immunoglobulin heavy chain
(IGH) genes have been found to be rearranged in T cell leuke-
mias2 and T cell antigen receptor a, b, g and d (TCRA, TCRB,
TCRG and TCRD) gene rearrangements have been reported in
B cell precursor leukemias.3 Moreover, we and other groups
have demonstrated the presence of gene rearrangement in
case of ANLL (Ref. 4 and references therein). In this latter type
of leukemias, the rearrangement of immunoglobulin (Ig) genes
involves the IGH (10%) and Ig kappa light chain (IGK) (5%)
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genes whereas rearrangement of the Ig lambda gene (IGL) has
never been reported.
In a series of 160 ANLL, we have systematically analyzed
by Southern blot the genomic organization of the Ig and TCR
genes and observed one patient that displayed rearranged IGH
and IGL genes.4 The patient, a 56-year-old male with a 2 week
history of systemic symptoms, showed pallor without lymph
node enlargement or hepato-splenomegaly in the physical
examination. The blood count showed: Hb: 9.1 g/dl, platelets:
130 · 109/l, white blood cells: 2.9 · 109/l, with 43% granulo-
cytes, 54% mature lymphocytes and 3% monocytes. No blast
cells were observed in the peripheral blood. The bone marrow
aspirate showed 60% of blasts cells displaying myeloid mor-
phology and an increase of megaloblastic erythroid precursor
with periodic acid Schiff (PAS) stain positivity (55%). A diag-
nosis of AML-M6 was established. Immunophenotypical stud-
ies showed that the blast cells expressed the myeloid antigen
CD13 (80%) and a minor proportion the CD11b and CD71
antigens, while the CD14 antigen was negative, as well as
markers for the megakaryocytic lineage (CD61 and CD41).
Blast cells were negative for TdT and expressed neither B-
lymphoid (CD19, CD20, CD10) nor T-lymphoid (CD3, CD7)
antigens. Treatment with a conventional 3–7 day course of
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daunomycin and Ara-C was started but the patient died of
septic shock during the aplastic phase of the first course.
Southern blot analysis of DNA with the probe pC76R51A,
a 2.5 kb EcoRI–BgIII genomic fragment containing the joining
region of the IGH locus, demonstrated a single rearranged
band after double and simple digestion (Figure 1). Hybridiz-
ation with pBCk, a 2.5 kb EcoRI–EcoRI probe derived from the
constant region of the IGK locus, failed to detect any
rearranged band. However, the germline fragment was fainter
in the patient than in the control DNA (Figure 1). Moreover,
hybridization with the Kde probe, a 2.5 kb HindIII–BamHI
fragment derived from the kappa deleting element allowed us
to demonstrate the presence of two rearranged bands, which
suggest that both alleles might be deleted and that the faint
germline band might correspond to contamination by residual
non-leukemic cells (Figure 1). Analysis of the genomic organi-
zation of the IGL locus with HulC2,C3, a 8 kb EcoRI–HindIII
fragment that contains Cl2 and Cl3, demonstrated rearrange-
ment of this gene after digestion with different restriction
enzymes (Figure 1).
Rearrangement of the IGH genes has been previously
reported to ocur in around 10% of cases of ANLL and a min-
ority of these cases also show concomitant rearrangement at
the IGK locus (Ref. 4 and references therein). Rearrangement
of the IGL locus only occurs when kappa light chain gene
rearrangement fails to generate a productive rearrangement
what makes this rearrangement the ultimate to occur during
B-lymphocyte differentiation. The absence of cases displaying
isolated Ig light chain gene rearrangements in ANLL supports
the notion that rearrangement of the Ig light chain locus
requires previous IGH gene rearrangement5 and that the leu-
kemic cells maintain the normal hierarchy of gene rearrange-
ment. Moreover, IGL gene rearrangement has only been
described in leukemias of the B cell lineage probably due to
the fact that it is an event that occurs late during B-lympho-
cyte development.
The present study illustrates a case displaying morphologi-
Figure 1 Southern blot analysis of the IGH, IGK and IGL genes. (P, DNA from the patient; C, DNA from a control). The arrows point to the
rearranged fragments.
cal and immunological criteria of ANLL that showed a
rearrangement of the IGL locus. Although the use of cytoplas-
mic CD22 or CD79a would be of additional value to rule out
a B-lineage origin, cells were not available for these additional
tests. Nevertheless, the negativity for TdT, CD19, CD20 and
CD10 are clearly against a B cell origin.
To the best of our knowledge, this is the first reported case
of ANLL rearranging the IGL locus. The detection of a biallelic
deletion at the IGK locus suggests that the leukemic clone is
derived from a cell in which the hierarchy of Ig gene rearrange-
ments has been maintained. The nature of this lineage infidelity
is unclear. As recently proposed6 these leukemias could result
from a transformational event occurring at an early stage of
normal hematopoietic development in a bipotential cell with
the genetic program of both lymphoid and myeloid cells. Alter-
natively, myeloid leukemic cells displaying Ig gene rearrange-
ment might represent a lymphoid cell whose differentiation
program has gone astray, leading to inappropriate expression
of genes from the wrong lineage. Another plausible explanation
for cross-lineage Ig locus rearrangement in AML is the aberrant
activity of the recombinase enzyme system in a myeloid precur-
sor cell resulting in an otherwise ‘normal’ hierarchical Ig gene
rearrangement pattern.
Acknowledgements
The authors thank TH Rabbitts and JJM van Dongen for pro-
viding us with the probes used in our study. This work was
supported by grants FISSs 89/0589 and CICYT SAF 92/0040.
I Sa´nchez-Garcı´a1 1Unidad de Medicina Molecular-
JF San Miguel2 Departamento de Medicina,
R Gonza´lez-Sarmiento1 2Servicio de Hematologı´a-Hospital
Universitario,
Universidad de Salamanca,
Salamanca, Spain
Correspondence
487
References
1 Sawyers CL, Denny CT, Witte ON. Leukemia and the disruption
of normal hematopoiesis. Cell 1991; 64: 337–350.
2 Kitchingman GR, Rovigatti V, Maner AM, Melvin S, Murphy S-B,
Stass S. Rearrangement of immunoglobulin heavy chain genes in
T cell acute lymphoblastic leukemia. Blood 1985; 65: 725–729.
3 Hara J, Benedict SH, Champagne E, Mak TW, Minden M, Gelfand
EW. Relationship between rearrangement and transcription of the
T cell receptor a, b, and g genes in B-precursor acute lymphoblas-
tic leukemia. Blood 1989; 73: 500–508.
4 Sanchez I, San Miguel JF, Corral J, Martı´n C, Pe´rez R, Gonza´lez
M, Can˜izo MC, Orfao A, Gonza´lez-Sarmiento R. Gene rearrange-
ment in acute non-lymphoblastic leukemia: correlation with mor-
phological and immunophenotypic characteristics of blast cells.
Br J Haematol 1995; 89: 104–109.
5 Korsmeyer SJ, Hieter PA, Sharrow SO, Goldman CK, Leder P,
Waldmann TA. Normal human B cells display ordered light chain
gene rearrangements and deletions. J Exp Med 1982; 156: 975–
985.
6 Bonnet D, Dick JE. Human acute myeloid leukemia is organized
as a hierarchy that originates from a primitive hematopoietic cell.
Nature Med 1997; 3: 730–737.
